Back
Grace Therapeutics Stock Price Chart

Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
GRCE
Grace Therapeutics
Last Price:
$2.37
Seasonality Move:
-1.52%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRCE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Grace Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.44 | Sell |
20-day SMA: | 2.86 | Sell |
50-day SMA: | 3.33 | Sell |
200-day SMA: | 3.11 | Sell |
8-day EMA: | 2.42 | Sell |
20-day EMA: | 2.75 | Sell |
50-day EMA: | 3.12 | Sell |
200-day EMA: | 3.17 | Sell |
Grace Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 31.41 | Sell |
Chaikin Money Flow: | 33396 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.53 - 3.41) | Sell |
Bollinger Bands (100): | (2.93 - 3.87) | Sell |
Grace Therapeutics Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Grace Therapeutics Stock
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 2.29 while GRCE 8-day simple moving average is 2.44, which is a Sell signal.
-
The stock price of GRCE is 2.29 while Grace Therapeutics 20-day SMA is 2.86, which makes it a Sell.
-
Grace Therapeutics 50-day simple moving average is 3.33 while GRCE share price is 2.29, making it a Sell technically.
-
GRCE stock price is 2.29 and Grace Therapeutics 200-day simple moving average is 3.11, creating a Sell signal.
GRCE Technical Analysis vs Fundamental Analysis
Sell
28
Grace Therapeutics (GRCE)
is a Sell
Is Grace Therapeutics a Buy or a Sell?
-
Grace Therapeutics stock is rated a SellThe current Grace Therapeutics [GRCE] share price is $2.29. The Score for GRCE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Grace Therapeutics Stock Info
Market Cap:
31.4M
Price in USD:
2.29
Share Volume:
33.4K
Grace Therapeutics 52-Week Range
52-Week High:
4.97
52-Week Low:
2.07
Sell
28
Grace Therapeutics (GRCE)
is a Sell
Grace Therapeutics Share Price Forecast
-
What is the Grace Therapeutics stock price today?The Grace Therapeutics stock price is 2.29 USD today.
-
Will GRCE stock go up or go down?Grace Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Grace Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics is overvalued.
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 2.29 while GRCE 8-day exponential moving average is 2.42, which is a Sell signal.
-
The stock price of GRCE is 2.29 while Grace Therapeutics 20-day EMA is 2.75, which makes it a Sell.
-
Grace Therapeutics 50-day exponential moving average is 3.12 while GRCE share price is 2.29, making it a Sell technically.
-
GRCE stock price is 2.29 and Grace Therapeutics 200-day simple moving average is 3.17, creating a Sell signal.
Fundamental Analysis of Grace Therapeutics
Is Grace Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.20 per share, and an increase next year of $0.40 per share.
Technical Analysis of Grace Therapeutics
Should I short Grace Therapeutics stock?
-
GRCE Moving Average Covergence Divergence (MACD) indicator is -0.31, suggesting Grace Therapeutics is a Sell
-
Grace Therapeutics Relative Strength Index (RSI) is 31.41, which suggest Grace Therapeutics is oversold
-
The Bollinger Bands (25) for Grace Therapeutics is (2.53 - 3.41), which suggest Grace Therapeutics is a Sell
-
The Bollinger Bands (100) for Grace Therapeutics is (2.93 - 3.87), which suggest Grace Therapeutics is a Sell
* Grace Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.